Herwig P. Moll
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.
Journal: Cancer letters
Published: November 11, 2025
A non-enzymatic role of Nudix hydrolase 5 in repressing purine de novo synthesis.
Journal: Science (New York, N.Y.)
Published: November 06, 2025
KRAS mutated lung adenocarcinoma responds to pan-ERBB and Aurora kinase inhibitors.
Journal: NPJ precision oncology
Published: May 02, 2025
Loss of SPHK1 fuels inflammation to drive KRAS-mutated lung adenocarcinoma.
Journal: Cancer letters
Published: October 18, 2024
RadioFlow Cytometry Reveals That [18F]FDG Uptake in K-RAS Lung Cancer Is Driven by Immune Cells: An Analysis on a Single-Cell Level.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 15, 2024
The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models.
Journal: Cancer research
Published: May 15, 2024
A Lung Cancer Mouse Model Database.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2024
Glucocorticoid receptor and RAS: an unexpected couple in cancer.
Journal: Trends in cell biology
Published: September 05, 2022
The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2022
A20/TNFAIP3 Increases ENOS Expression in an ERK5/KLF2-Dependent Manner to Support Endothelial Cell Health in the Face of Inflammation.
Journal: Frontiers in cardiovascular medicine
Published: January 08, 2021
Efficient production of recombinant secretory IgA against Clostridium difficile toxins in CHO-K1 cells.
Journal: Journal of biotechnology
Published: September 30, 2020
Last Updated: 09/26/2026